Clash Over Abortion Hobbles A Health Bill. Again. Here’s How.
As Congress considers a bipartisan bill to help hold down premium prices on the health law’s marketplaces, a long-standing fight over abortion reappears.
The independent source for health policy research, polling, and news.
761-780 of 1,000 results
As Congress considers a bipartisan bill to help hold down premium prices on the health law’s marketplaces, a long-standing fight over abortion reappears.
President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the problems that are making congressional efforts to pass legislation to stabilize the individual insurance market a long shot.
Last month’s budget deal means Medicare beneficiaries are eligible for physical and occupational therapy indefinitely. Plus, prescription drug costs will fall for more seniors.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and new podcast panelist Anna Edney of Bloomberg News discuss this week’s spate of speeches by the leaders of the Department of Health and Human Services. They also discuss the slow progress on health legislation on Capitol Hill intended to fund the government and stabilize the individual insurance market. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
The Trump administration has talked about prioritizing the opioid crisis, but states have seen little in the way of new resources. And, in some states, getting into treatment is becoming even harder.
Bipartisan efforts on Capitol Hill seek to help keep premium prices from rising out of control and undermining the policies available to people who don’t get insurance through work.
How physical and occupational therapists triumphed in a two-decade-long quest to overturn limits on their compensation.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Sarah Kliff of Vox discuss the latest lawsuit challenging the constitutionality of the Affordable Care Act. They also explore how your health care system increasingly depends on the state you live in. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Forty percent of people are unaware that Congress repealed the penalty for most people who don’t have insurance coverage starting in 2019.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Stephanie Armour of The Wall Street Journal and Julie Appleby of Kaiser Health News discuss the Trump administration’s proposed regulation that would allow the expansion of short-term health insurance policies that do not comply with all the requirements of the Affordable Care Act. The panelists also talk about federal funding (or not) of public health research around guns.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Stephanie Armour of The Wall Street Journal and Paige Winfield-Cunningham of The Washington Post discuss President Donald Trump’s budget plan and how some states are trying to stabilize the Affordable Care Act, while others are trying to violate it. Also, Rovner and KHN’s Sarah Jane Tribble interview Scott Gottlieb, commissioner of the Food and Drug Administration.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the health policy changes included in the just-concluded bipartisan budget deal on Capitol Hill. The panelists also talk about the final enrollment numbers for individual insurance purchased under the Affordable Care Act, and possible drug price proposals in President Donald Trump’s upcoming budget. Plus, Rovner interviews Andy Slavitt, who this week launched a health care advocacy group called “The United States of Care.”
The agreement would add $2 billion to the National Institutes of Health and fund community health centers around the country. But it does not include provisions to help stabilize the federal health law’s marketplaces.
The centers, which serve 27 million people, get about 20 percent of their funding from the federal government. But that revenue is slated to end on March 31.
With another piece of must-pass legislation set to move through Congress, there’s a push to attach provisions to keep afloat a number of health-related programs for which funding or specific federal direction has expired.
In this episode of “What The Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Paige Winfield Cunningham of The Washington Post discuss the short-term spending bill passed by Congress that reopened the federal government and funded the Children’s Health Insurance Program for six years. The panelists also discussed the health programs still awaiting funding, and the intersection of religion and women’s health services at the Department of Health and Human Services.
The Children's Health Insurance Program drew bipartisan support for two decades. After brinkmanship over the federal budget, an agreement to end the shutdown has assured CHIP funding for six years.
A KHN data analysis finds that the door of opportunities connecting Capitol Hill, the federal government and the drug industry likely spins in Big Pharma’s favor.
But advocates and consultants say the tax credits are unlikely to persuade many employers to offer such benefits.
© 2026 KFF